VVD-214
Asset
Inhibits Werner helicase, disrupting DNA repair in susceptible cancer cells.
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- wrn
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Advanced colorectal cancer
Phase 2, businesswire.com, Oct 15, 2026
In the full profile
- Target and mechanism1
- Owner and partners1
- Evidence for its targets1
- Competitors2
Every asset’s record: target, stage, trials and the evidence behind it.